abstract |
Therapeutic and/or preventive agents for diseases due to retinal ischemia (e.g., glaucoma, diabetic retinopathy, macular degeneration, or retinal vascular occlusion), containing as the active ingredient (2R)-N-(1-benzylpiperidin-4-yl)-3-cyclo- hexylmethylthio-2-((4R)-3-t-butoxycarbonylthiazolidin-4-yl-carbonylamino)propanamide (|) or nontoxic salts thereof. |